P4.26 ASSOCIATIONS BETWEEN FGF23-LEVEL AND ARTERIAL DISTENSIBILITY IN CHRONIC KIDNEY DISEASE

P4.26 ASSOCIATIONS BETWEEN FGF23-LEVEL AND ARTERIAL DISTENSIBILITY IN CHRONIC KIDNEY DISEASE

Vascular calcification and hemodynamical abnormalities lead to reduced arterial elasticity in end stage renal disease. Fibroblast growth factor-23 (FGF23) predicts cardiovascular mortality in advance stages of renal failure possibly indicating more advanced vascular calcification. The relation of FG...

Full description

Bibliographic Details
Main Authors:	O. Cseprekal, Németh Zs, A. Marton, E. Vámos, J. Nemcsik, J. Egresits, T. El Hajd Othmane, B. Fekete, Deák Gy, I. Kiss, A. Tislér
Format:	Article
Language:	English
Published:	Atlantis Press 2013-11-01
Series:	Artery Research
Online Access:	https://www.atlantis-press.com/article/125939041/view

Similar Items

P7.13 WHICH ARTERIAL STIFFNESS PARAMETER IS THE BEST PREDICTOR OF CARDIOVASCULAR MORTALITY IN HEMODIALYSIS PATIENTS?
by: Othmane T. El Hadj, et al.
Published: (2011-11-01)

P1.26 MICROVASCULAR REACTIVITY PARAMETERS FAIL TO PREDICT CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
by: J. Nemcsik, et al.
Published: (2013-11-01)

P.070 ARTERIAL STIFFNESS ALTERATIONS DURING HEMODIALYSIS
by: J. Egresits, et al.
Published: (2007-08-01)

P6.01 THE METHOD OF DISTANCE MEASUREMENT AND TORSO LENGTH INFLUENCES THE RELATIONSHIP OF PULSE WAVE VELOCITY TO CARDIOVASCULAR MORTALITY
by: J. Nemcsik, et al.
Published: (2011-11-01)

3.1 INTEGRATED CENTRAL PRESSURE-STIFFNESS RISK SCORE: A NEW OPPORTUNITY FOR CARDIOVASCULAR RISK STRATIFICATION. FIRST RESULTS ON CHRONIC KIDNEY DISEASE PATIENTS
by: János Nemcsik, et al.
Published: (2017-12-01)

P.021 RENAL INSUFFICIENCY IS ASSOCIATED WITH AUGMENTATION INDEX AND ENDOTHELIAL DYSFUNCTION
by: J. Egresits*, et al.
Published: (2007-06-01)

Integrated Central Blood Pressure-aortic Stiffness Risk Categories and Cardiovascular Mortality in End-stage Renal Disease
by: Dóra Batta, et al.
Published: (2019-11-01)

P4.26 ADIPOCYTOKINES LEVELS MARK ENDOTHELIAL FUNCTION IN NORMOTENSIVE INDIVIDUALS
by: R.M. Bruno, et al.
Published: (2012-11-01)

05.03 OSTEOPROTEGERIN IS RELATED TO CAROTID-FEMORAL PULSE WAVE VELOCITY AND SURVIVAL IN HEMODIALYSIS PATIENTS
by: J. Nemcsik, et al.
Published: (2007-08-01)

P.022 VALIDITY OF THE TENSIOCLINIC DEVICE TO MEASURE ARTERIAL STIFFNESS IN PATIENTS ON HEMODIALYSIS
by: T. el Hadj Othmane*, et al.
Published: (2007-06-01)

FGF-23: estado da arte FGF-23: state of the art
by: Rodrigo Bueno de Oliveira, et al.
Published: (2010-09-01)

FGF23, Biomarker or Target?
by: Cristian Rodelo-Haad, et al.
Published: (2019-03-01)

P126 THE ASSOCIATION OF THE INTEGRATED CENTRAL PRESSURE-STIFFNESS RISK SCORE WITH CARDIOVASCULAR MORTALITY IN HEMODIALYSIS PATIENTS
by: János Nemcsik, et al.
Published: (2018-12-01)

Il Fibroblast Growth Factor-23 (FGF-23)
by: D. Rendina, et al.
Published: (2018-01-01)

Normal Splenic Volume Assessment on CT in 426 Adults
by: Sitthipong Srisajjakul, et al.
Published: (2020-07-01)

Role of FGF23 in Pediatric Hypercalciuria
by: Maria Goretti Moreira Guimarães Penido, et al.
Published: (2017-01-01)

Paracrine Effects of FGF23 on the Heart
by: Maren Leifheit-Nestler, et al.
Published: (2018-05-01)

FGF23 Producing Mesenchymal Tumor
by: Lucyna Papierska, et al.
Published: (2014-01-01)

FGF23 - a possible Phosphatonin
by: Marsell, Richard
Published: (2008)

FGF23 in Acute and Chronic Illness
by: Christian Schnedl, et al.
Published: (2015-01-01)

FGF23, Hypophosphatemia, and Emerging Treatments
by: Erik A Imel, et al.
Published: (2019-08-01)

PILOTSTUDY TO EVALUATE THE EFFECT OF PHOSPHORUSBINDERS ON FGF23
by: A.Bouma de Krijger, et al.
Published: (2012-06-01)

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
by: Aneta Cymbaluk-Płoska, et al.
Published: (2020-06-01)

Man with Abdominal Distension
by: Caleb P. Canders, et al.
Published: (2014-07-01)

Testing the renal signaling axis for FGF23
by: Ni, Pu
Published: (2016)

Osteocytic FGF23 and Its Kidney Function
by: Rafiou Agoro, et al.
Published: (2020-08-01)

Phosphate Homeostasis, Inflammation and the Regulation of FGF-23
by: Florian Lang, et al.
Published: (2018-11-01)

FGF23 and Phosphate–Cardiovascular Toxins in CKD
by: Isabel Vogt, et al.
Published: (2019-11-01)

Clinical Significance of FGF-23 in Patients with CKD
by: Domenico Russo, et al.
Published: (2011-01-01)

PKC regulates the production of fibroblast growth factor 23 (FGF23).
by: Ludmilla Bär, et al.
Published: (2019-01-01)

Fibroblast Growth Factor-23 (FGF-23) e Sindrome Cardiorenale
by: Luca Di Lullo, et al.
Published: (2015-03-01)

P.051 EVALUATION OF ENDOTHELIAL FUNCTION WITH NON-INVASIVE METHODS IN DIFFERENT CARDIOVASCULAR DISEASES
by: J. Nemcsik*, et al.
Published: (2007-06-01)

Three-Dimensional Analysis of the Curvature of the Femoral Canal in 426 Chinese Femurs
by: Xiu-Yun Su, et al.
Published: (2015-01-01)

Re‐evaluation of soybean hemicellulose (E 426) as a food additive
by: EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), et al.
Published: (2017-03-01)

Vilaça, Adilson (2015). Cotaxé. Lisboa: Chiado Editora, pp. 426
by: Regazzoni, Susanna
Published: (2016-06-01)

Frequent Transposition of Multiple Insertion Sequences in Geobacillus kaustophilus HTA426
by: Hirokazu Suzuki, et al.
Published: (2021-03-01)

Enzo Croatto, Vocabolario ampezzano, Cortina d'Ampezzo, 1986; XXX + 426 pagine.Enzo Croatto, Vocabolario ampezzano, Cortina d'Ampezzo, 1986; XXX + 426 pagine
by: Mitja Skubic
Published: (1997-12-01)

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
by: Franz Ewendt, et al.
Published: (2021-01-01)

¿Tensión o distensión urbana?
by: Roberto Lira Olmo
Published: (2012-05-01)

Distension and dissension : Artforum and the seventies
by: McNally, Simon
Published: (2010)